MIRAGEN THERAPEUTICS, INC. Stock Agreements
5 Contracts & Agreements
- 2016 Amended and Restated Employee Stock Purchase Plan (Filed With SEC on February 27, 2024)
- Common Stock Purchase Agreement, dated December 11, 2019 between Miragen Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on December 11, 2019)
- Common Stock Purchase Agreement, dated August 6, 2018, by and between the Registrant and The Leukemia & Lymphoma Society, Inc (Filed With SEC on November 7, 2018)
- MIRAGEN THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT (Filed With SEC on March 31, 2017)
- SIGNAL GENETICS, INC.By:/s/ Bennett S. LeBow Bennett S. LeBowChairman of the Board of DirectorsAcknowledged: /s/ Samuel D. Riccitelli Samuel D. Riccitelli [Signature page to... (Filed With SEC on March 27, 2015)
